Elyns Group strictly follows the plagiarism policy of the Committee on Publication Ethics (COPE). Plagiarism in any form (Self, Direct, Mosaic and accidental) is not acceptable. Thus, we strongly suggest that all authors check manuscript content before submission. Elyns Group uses Ithenticate to ensure the manuscript is free of plagarized text and data.
Cover letter should contain an official statement of approval by all participating authors declaring the submission to the particular journal. The letter should specify the elaborated title, list of authors with affiliations, correspondence address, ratio of contribution, and conflicts of interest. The letter should give any additional information that may be helpful to the editor, such as the type of article, information on prior or duplicate publication or parallel submission of any part of the work in journals elsewhere, and whether the author(s) will be willing to meet the processing charges. Include copies of any permissions needed to reproduce published material or to use illustrations of identifiable subjects.
Manuscripts are accepted only in word document format (.doc or .docx). Figure of high definition only in Jpeg/Jpg/Tiff formats are acceptable. Tables and graphs with legends should be submitted in separate word documents.
The participating authors should meet the following criteria to be listed in the publication.
1. Direct or indirect contribution in the process of planning, designing, implementation, data collection/acquisition and organization.
2. Involvement in intellectual data compilation i.e. documentation, edition, and revision.
3. Indulge in the approval for the submission of final version.
4. Bearing responsibility and accountability for the metadata.
Declaration of Conflicts of Interest
Every author of the manuscript should disclose conflict of interest statement along with the manuscript. It is mandate to submit the COI form even in the case of no conflicts.
Authors may download the COI form from ICMJE and submit the filled form to the journal along with the manuscript.
Any research involved in occasional/intentional/regular usage of animals, human clinical trials should get the appropriate approvals from the concerned authorities. The corresponding information such as approval details, name of the relevant ethics committee and the reference number for their judgment should be stated in the cover letter.
Clinical Trial Information
Standardized and authorized protocols should be followed for conducting and reporting the clinical trials on humans. Renowned reporting guidelines like CONSORT, PRISMA, STROBE, COREQ, ENTREQ, SAMPL etc. provided by Equator network & NLM's Research Reporting Guidelines should be followed for enhancing the quality and transparency of health research.
The title page of the manuscript should contain short yet descriptive title of the manuscript (Should not exceed 15 words), list of authors with their highest academic degrees and affiliations (address of the University where the research was conducted), details of the corresponding authors including name and complete address with telephone, fax numbers and e-mail address, word count, number of tables and figures, sources of support, any disclaimers and conflict of interest declaration.
The original research articles, systematic reviews, meta-analyses and case reports require structured abstracts. The abstract should provide the context or background for the study and should state the study's purpose, basic procedures, main findings, and principal conclusions. It should highlight novel and significant aspects of the study or observations, note important limitations. Authors need to ensure that abstract should accurately reflect the content and should not be same as introduction and others sections. Authors need to provide the clinical trials registration numbers (for clinical trials) at the end of the abstract.
Three to six words which explain the research briefly and have direct connection with the script can be used as keywords
All the abbreviations which are used in the article should be listed here.
Introduction should provide the context or background for the study and state the purpose or research objectives, hypothesis of the study or the observation. The content in the introduction should be cited properly using the latest references. Avoid providing unrelated and unlimited information.
An elaborated description containing design, various protocols, techniques, instruments used for the experimental conduct and proof in support of proposed hypothesis or theory should be covered. This category should rationally explain why and how the specified experimental approaches are adopted. This section should exclusively cover experimental details that were listed in the protocol before starting the experiments, all information obtained during the study should be provided in the Results section. Standard protocols should be credited with appropriate citations.
A logical sequence for the presentation of results (text, tables, and figures) should be followed in the order of significance. The most important findings should be prioritized. Detailed representation of primary and secondary outcomes identified in the methods section is highly suggested. The results should be presented in tables and figures at the places of demand to improve the accessibility of the data. Do not repeat all the data in the tables or figures in the text.
A clear linking of the main findings with the purpose of the study should be explicitly discussed in this section. A logical conclusion, interpretation and data generation from the experimental study should be the aim of this section. For experimental studies, it is useful to begin the discussion by briefly summarizing the main findings, then explore possible mechanisms or explanations for these findings, compare and contrast the results with other relevant studies, state the limitations of the study, and explore the implications of the findings for future research and for clinical practice.
This contains the details of financial and moral support to the authors, grants, funding agencies, partners, collaborations, etc.
References of the articles, books, conferences, blogs, website, should be distinctly distinguished. The reference should contain names of the authors, title of the reference article/book, name of the journal/publisher, year of publication, volume number/edition and page number. References are numbered consecutively in the order in which they are first cited in the text.
References should follow the standards summarized in the NLM's International Committee of Medical Journal Editors (ICMJE) Recommendations
Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002 Jul 25; 347(4):284-7.
Tables should be uploaded at the end of the document after the “References section”. Tables should have a short descriptive title, should be numbered in Arabic numerals, and cited in the text. Symbols and abbreviations represented in the table should be explained in footnotes, below the table. For ex: The results from the In-Vitro dissolution testing are presented in Table 1. Figures should be uploaded at the end of the document after the “Tables”. A suitable title and short explanation should be provided in figure legends. Figures should be numbered in Arabic numerals and cited in the text. Good quality image should be provided.
Authors may submit the manuscript online via
Detailed submission: www.elynsgroup.com/manuscript
Quick Submission: www.elynsgroup.com/manuscript/quicksubmission
E mail Submission: email@example.com
However, a detailed submission of the manuscript is always preferable and in case of any technical problems you may submit the manuscript as an email attachment with complete author(s) details.
ELYNS Publishing Group, a self-supporting organization does not receive funding from any funding agency or supporting authority. As all the journals organized by ELYNS are Open access, we do not charge any subscription charges from the reader. All the operations are self-financed by the organization. The only way to meet the expenses is the publication charges from authors. This is to cover the expenses towards plagiarism check, reviewing, proof reading, typesetting, web-maintenance, permanent online archiving of the articles at elynsgroup.com, etc. However there are no submission charges and authors can pay the fee after the acceptance of article for publication.
On each successful submission of the manuscript, the author will be acknowledged accordingly. All the manuscripts are subjected to plagiarism check and pre QC Check. Once the manuscript is accepted in pre QC, it will be assigned to one of our most eminent editors of relevant expertise. The editor has the privilege of accepting/rejecting/suggest for revision of the manuscript based on the quality. The editor may also assign the work of reviewing the manuscript to 2-3 reviewers of same expertise. The reviewers have the freedom to accept/reject/suggest for revision of the manuscript based on the quality and novelty of the paper. The articles will be accepted if at least 2 out of 3 (majority) express their acceptance. If any reviewer suggests for revision i.e. major or minor, corresponding author will be notified for the revision (with suggested amendments) towards the publication. If at least 2 out of 3 (majority) suggest to reject the article, it will be rejected and author will be intimated accordingly.
The revised manuscripts will be cross checked with the reviewer’s comments and published with their acceptance. However the editor’s decision is final in any stage of the editorial process. Articles submitted to other journals, published articles, articles with plagiarism, copied articles without any reference will be strictly rejected. ELYNS follows fast track 14 days peer review process (*provided all the details are accurate). Full texts and PDF formats of the accepted articles will be made available on line with in 5-7 days of acceptance at Article in press.